STOCK TITAN

Dynatronics Corp. - DYNT STOCK NEWS

Welcome to our dedicated news page for Dynatronics (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Dynatronics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Dynatronics's position in the market.

Rhea-AI Summary
Dynatronics Corporation (NASDAQ: DYNT) reported financial results for its second quarter of fiscal year 2024, showing progress towards sales goals and positive EBITDA. The company plans to launch new products in the third and fourth quarters of fiscal year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-30.88%
Tags
earnings
-
Rhea-AI Summary
Dynatronics Corporation (NASDAQ: DYNT) will release its financial results for the second quarter of fiscal year 2024 on February 8, 2024. The company will also hold a conference call with analysts to review the results. Interested persons can access the live conference call by dialing 1-800-319-4610 (U.S./Canada callers) or +1-604-638-5340 (international callers). An audio replay will be available until February 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
conferences earnings
-
Rhea-AI Summary
Dynatronics Corporation (NASDAQ: DYNT) announced the appointment of Andrew Hulett to its Board of Directors, filling the vacancy created by Scott Klosterman's resignation. Hulett brings extensive experience in business development, particularly in HR outsourcing services, and has successfully led the sale of businesses in the past. His appointment is expected to provide additional resources for the company's business strategies and growth opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary
Leixir Dental Laboratory Group (Leixir) (NASDAQ: LDXR) appoints John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries, succeeding founder Harmeet Bindra who continues as Executive Chairman. The appointment aims to drive operational excellence and expand Leixir's customer base, DSO relationships, and service offerings to support best-in-class dental patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.69%
Tags
management
-
Rhea-AI Summary
DYNT: Dynatronics Corporation Reports Q1 Fiscal Year '24 Financial Results, Reaffirms Guidance, and Announces Conference Call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8%
Tags
earnings
-
Rhea-AI Summary
Dynatronics Corporation appoints Gabe Ellwein as Chief Financial Officer, effective October 30, 2023. Ellwein will lead the company's finance, accounting, and investor relations teams. He brings extensive experience in finance, manufacturing, supply chain, and product leadership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary
Dynatronics Corporation to release financial results for its fiscal year first quarter on November 9, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary
Dynatronics Corporation promotes Brian Baker to CEO and appoints him to the Board of Directors, following the resignation of former CEO John Krier. Krier will remain as an executive consultant and Interim CFO. Baker's history in the business, relationships, and employee support position him well. Baker previously served as President, COO, and President of the Therapeutic Products Division at Dynatronics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
none
-
Rhea-AI Summary
Dynatronics Corporation reports financial results for Q4 and FY '23, with total net sales of $8.4 million and $40.6 million respectively. Gross profit margin was 14.7% for Q4 and 25.0% for FY '23. Net loss was $2.4 million for Q4 and $5.0 million for FY '23. The company expects net sales for FY '24 to be $34 million to $37 million, with distribution aligning with historical trends. Financial guidance subject to risks from economic challenges and business optimization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
earnings
Rhea-AI Summary
Dynatronics Corporation to release Q4 and FY 2023 financial results on September 28, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
Dynatronics Corp.

Nasdaq:DYNT

DYNT Rankings

DYNT Stock Data

2.18M
2.36M
32.5%
8.27%
0.4%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Eagan

About DYNT

dynatronics manufactures, markets, and distributes advanced-technology medical devices, treatment tables, and rehabilitation - acute-care - sport medicine - chiropractic - massage equipment as well as over 8,000 products and supplies. in addition, dynatronics has the most experienced and knowledgeable sales force in the industry. with more than 60 sales representatives and 150 active distributors located throughout the country, we are able to provide immediate service. dynatronics has built a solid reputation over the past 31 years for competitive pricing, excellent customer service, and unmatched clinical support. our field support team handles everything from equipment set-up to in-service training.